Company Profile
Neurocrine Biosciences Stock Price, News & Analysis
Company overview
Business overview
Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company with a commercial base and a pipeline tied to movement disorders and other specialty indications. Investors watch how the company extends its franchise beyond the lead commercial asset.
Geographic Base and Sector Classification
Headquartered in San Diego, California and listed on NASDAQ, Neurocrine is followed within the neuroscience universe for its commercial base and specialty-disease exposure.
Business Model Characteristics
Neurocrine combines product commercialization with pipeline development, so the market focuses on launch execution, label expansion, and the next wave of neuroscience programs.
Position Within the Biotechnology Landscape
Compared with smaller biotech peers, Neurocrine sits closer to the commercial-neuroscience end of the landscape, where execution and pipeline renewal both matter.
Why the stock is moving
NBIX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Neurocrine’s watchlist is Ingrezza growth, the next CNS pipeline readout, and the company’s ability to keep the commercial base expanding. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results
Source: Neurocrine Biosciences
- 03
- 04
Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
Source: Neurocrine Biosciences
- 05
Neurocrine Biosciences to Present at the Bank of America Health Care Conference 2026
Source: Neurocrine Biosciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.